Followers | 375 |
Posts | 16968 |
Boards Moderated | 4 |
Alias Born | 03/07/2014 |
Monday, June 02, 2014 1:49:26 PM
No more complicated than that. FDA phase II/III "trials" and actual "medical research" on about $3K a month "budget", but $5K goes to some penny stock "promotion firm" for one month's worth of "services"? Really? Nothing wrong with that picture?
And they have 4 full time and one part time "employee" (latest 10-Q) and just gave the two "important" people, 50% boosts in their base salaries and essentially a TRIPLE of their "total compensation" packages (including BONUSES), bringing the CEO total "comp package" to close to $1 MILLION a yr, at the same time that "R&D" spending went close to nothing for the quarter, and while their SG&A expenses doubled at the same time, from $370,533 same period last yr, to $838,329 Q-1 this yr (most recent 10-Q, PAGE 5 and last 10-K, "compensation table" PAGE 71).
I guess there's a reason people like the SEC and U.S. govt. regulatory system invented things like a 10-K and 10-Q, else, no one would ever know, would they? We'd sure never hear about any of those FACTS in all the good ole, "PR releases" or "blogs" or "podcasts", that's for certain, IMO.
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM